|
KMID : 0604520160420020111
|
|
Journal of the Society of Cosmetic Scientists of Korea
2016 Volume.42 No. 2 p.111 ~ p.118
|
|
|
Efficacy and Safety of Topical Application of Epidermal Growth Factor (EGF) for Korean Acne Patient
|
|
Suh Joon-Hyuk
Hyun Moo-Yeol
Chang Sung-Eun
Choi Sun-Young
Kim Myeung-Nam
Kim Beom-Joon
|
|
|
Abstract
|
|
|
|
Acne vulgaris is a chronic inflammatory condition characterized by comedo, papule, cyst, nodule and postinflammatory hyperpigmentation. Meanwhile, it is also induced by adverse event of drugs. Among them, acneiform folliculitis is a side effect of epidermal growth factor receptor (EGFR) inhibitor, which is an anticancer agent, and its incidence may occur in upward of 75 ∼ 100% of cases. The main method of acne vulgaris treatment is oral antibiotics, retinoids, topical medication and so on. However, it is limitation that teratogenicity caused by retinoids and antibiotic resistance increased by using antibiotics. In this study, we aimed to evaluate the clinical efficacy and safety of topical recombinant human (rh) EGF in treating facial acne vulgaris. Twenty three Koreans (age: 10 ∼ 29 years) with mild to moderate acne vulgar participated in the study and applied topical rhEGF cream (trouble control EGF) with 3 products (trouble control clarifying cleansing foam, trouble control all-clear filling toner, redroll calming moisture) on their face cetwice daily for four weeks. Several assessment methods were applied: Acne lesion counts score by investigator’s global assessment, efficacy and satisfaction score by subjects. Skin sebum output level, hydration level and redness level were also measured at each visit. At the final visit, skin sebum level, transepidermal water loss, skin redness statistically decreased and acne lesions (comedone, papule) were statistically reduced. No severe side effects were observed during the study. In conclusion, topical rhEGF seems to be an effective and safe adjuvant treatment option for mild acne vulgaris.
|
|
|
KEYWORD
|
|
|
acne vulgaris, epidermal growth factor, EGF, recombinant human EGF
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|